Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Dendritic cells and routing cargo into exosomes.

Leone DA, Rees AJ, Kain R.

Immunol Cell Biol. 2018 May 24. doi: 10.1111/imcb.12170. [Epub ahead of print] Review.

PMID:
29797348
2.

Surface LAMP-2 Is an Endocytic Receptor That Diverts Antigen Internalized by Human Dendritic Cells into Highly Immunogenic Exosomes.

Leone DA, Peschel A, Brown M, Schachner H, Ball MJ, Gyuraszova M, Salzer-Muhar U, Fukuda M, Vizzardelli C, Bohle B, Rees AJ, Kain R.

J Immunol. 2017 Jul 15;199(2):531-546. doi: 10.4049/jimmunol.1601263. Epub 2017 Jun 12.

3.

Adhesion of Escherichia coli under flow conditions reveals potential novel effects of FimH mutations.

Feenstra T, Thøgersen MS, Wieser E, Peschel A, Ball MJ, Brandes R, Satchell SC, Stockner T, Aarestrup FM, Rees AJ, Kain R.

Eur J Clin Microbiol Infect Dis. 2017 Mar;36(3):467-478. doi: 10.1007/s10096-016-2820-8. Epub 2016 Nov 5.

4.

The Phenotypic Characterization of the Human Renal Mononuclear Phagocytes Reveal a Co-Ordinated Response to Injury.

Leone DA, Kozakowski N, Kornauth C, Waidacher T, Neudert B, Loeffler AG, Haitel A, Rees AJ, Kain R.

PLoS One. 2016 Mar 21;11(3):e0151674. doi: 10.1371/journal.pone.0151674. eCollection 2016.

5.

Coming of Age--CC Chemokine Ligand 18 in ANCA-Associated Vasculitis.

Kain R, Rees AJ.

J Am Soc Nephrol. 2015 Sep;26(9):2065-7. doi: 10.1681/ASN.2015020138. Epub 2015 Mar 11. No abstract available.

6.

All of the twos, 22-bingo!

Rees AJ.

J Am Soc Nephrol. 2014 May;25(5):866-9. doi: 10.1681/ASN.2014020138. Epub 2014 Mar 7. No abstract available.

7.

Autoantibodies in anti-neutrophil cytoplasm antibody-associated vasculitis.

Salama AD, Rees AJ.

Nephrol Dial Transplant. 2014 Jun;29(6):1105-7. doi: 10.1093/ndt/gft526. Epub 2014 Jan 23. No abstract available.

PMID:
24459139
8.

Autoantibodies to hLAMP-2 in ANCA-negative pauci-immune focal necrotizing GN.

Peschel A, Basu N, Benharkou A, Brandes R, Brown M, Dieckmann R, Rees AJ, Kain R.

J Am Soc Nephrol. 2014 Mar;25(3):455-63. doi: 10.1681/ASN.2013030320. Epub 2013 Nov 7. Erratum in: J Am Soc Nephrol. 2018 Feb;29(2):704.

9.

A critical role for suppressor of cytokine signalling 3 in promoting M1 macrophage activation and function in vitro and in vivo.

Arnold CE, Whyte CS, Gordon P, Barker RN, Rees AJ, Wilson HM.

Immunology. 2014 Jan;141(1):96-110. doi: 10.1111/imm.12173.

10.

The immune system and kidney disease: basic concepts and clinical implications.

Kurts C, Panzer U, Anders HJ, Rees AJ.

Nat Rev Immunol. 2013 Oct;13(10):738-53. doi: 10.1038/nri3523. Epub 2013 Sep 16. Review.

PMID:
24037418
11.

What is the evidence for antibodies to LAMP-2 in the pathogenesis of ANCA associated small vessel vasculitis?

Kain R, Rees AJ.

Curr Opin Rheumatol. 2013 Jan;25(1):26-34. doi: 10.1097/BOR.0b013e32835b4f8f. Review.

PMID:
23169102
12.

2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA.

Arthritis Rheum. 2013 Jan;65(1):1-11. doi: 10.1002/art.37715. No abstract available.

13.

Characterisation of tumour-infiltrating macrophages: impact on response and survival in patients receiving primary chemotherapy for breast cancer.

Heys SD, Stewart KN, McKenzie EJ, Miller ID, Wong SY, Sellar G, Rees AJ.

Breast Cancer Res Treat. 2012 Sep;135(2):539-48. doi: 10.1007/s10549-012-2190-6. Epub 2012 Aug 11.

PMID:
22886449
14.

Genetically distinct subsets within ANCA-associated vasculitis.

Lyons PA, Rayner TF, Trivedi S, Holle JU, Watts RA, Jayne DR, Baslund B, Brenchley P, Bruchfeld A, Chaudhry AN, Cohen Tervaert JW, Deloukas P, Feighery C, Gross WL, Guillevin L, Gunnarsson I, Harper L, Hrušková Z, Little MA, Martorana D, Neumann T, Ohlsson S, Padmanabhan S, Pusey CD, Salama AD, Sanders JS, Savage CO, Segelmark M, Stegeman CA, Tesař V, Vaglio A, Wieczorek S, Wilde B, Zwerina J, Rees AJ, Clayton DG, Smith KG.

N Engl J Med. 2012 Jul 19;367(3):214-23. doi: 10.1056/NEJMoa1108735.

15.

High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis.

Kain R, Tadema H, McKinney EF, Benharkou A, Brandes R, Peschel A, Hubert V, Feenstra T, Sengölge G, Stegeman C, Heeringa P, Lyons PA, Smith KG, Kallenberg C, Rees AJ.

J Am Soc Nephrol. 2012 Mar;23(3):556-66. doi: 10.1681/ASN.2011090920. Epub 2012 Feb 9.

16.

The renal mononuclear phagocytic system.

Nelson PJ, Rees AJ, Griffin MD, Hughes J, Kurts C, Duffield J.

J Am Soc Nephrol. 2012 Feb;23(2):194-203. doi: 10.1681/ASN.2011070680. Epub 2011 Dec 1. Review.

17.

Suppressor of cytokine signaling (SOCS)1 is a key determinant of differential macrophage activation and function.

Whyte CS, Bishop ET, Rückerl D, Gaspar-Pereira S, Barker RN, Allen JE, Rees AJ, Wilson HM.

J Leukoc Biol. 2011 Nov;90(5):845-54. doi: 10.1189/jlb.1110644. Epub 2011 May 31.

PMID:
21628332
18.

Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.

Stanescu HC, Arcos-Burgos M, Medlar A, Bockenhauer D, Kottgen A, Dragomirescu L, Voinescu C, Patel N, Pearce K, Hubank M, Stephens HA, Laundy V, Padmanabhan S, Zawadzka A, Hofstra JM, Coenen MJ, den Heijer M, Kiemeney LA, Bacq-Daian D, Stengel B, Powis SH, Brenchley P, Feehally J, Rees AJ, Debiec H, Wetzels JF, Ronco P, Mathieson PW, Kleta R.

N Engl J Med. 2011 Feb 17;364(7):616-26. doi: 10.1056/NEJMoa1009742.

19.

Genotypic diversity of complement component C4 does not predict kidney transplant outcome.

Wahrmann M, Döhler B, Ruhenstroth A, Haslacher H, Perkmann T, Exner M, Rees AJ, Böhmig GA.

J Am Soc Nephrol. 2011 Feb;22(2):367-76. doi: 10.1681/ASN.2010050513. Epub 2010 Dec 16.

20.

Monocyte and macrophage biology: an overview.

Rees AJ.

Semin Nephrol. 2010 May;30(3):216-33. doi: 10.1016/j.semnephrol.2010.03.002. Review.

PMID:
20620668
21.

HLA has strongest association with IgA nephropathy in genome-wide analysis.

Feehally J, Farrall M, Boland A, Gale DP, Gut I, Heath S, Kumar A, Peden JF, Maxwell PH, Morris DL, Padmanabhan S, Vyse TJ, Zawadzka A, Rees AJ, Lathrop M, Ratcliffe PJ.

J Am Soc Nephrol. 2010 Oct;21(10):1791-7. doi: 10.1681/ASN.2010010076. Epub 2010 Jul 1.

22.

The contribution of genetic variation and infection to the pathogenesis of ANCA-associated systemic vasculitis.

Willcocks LC, Lyons PA, Rees AJ, Smith KG.

Arthritis Res Ther. 2010;12(1):202. doi: 10.1186/ar2928. Epub 2010 Feb 15. Review.

23.

Variation in IGHMBP2 is not associated with IgA nephropathy in independent studies of UK Caucasian and Chinese Han patients.

Lou T, Zhang J, Gale DP, Rees AJ, Rhodes B, Feehally J, Li C, Li Y, Li R, Huang W, Hu B, Leung JC, Lam MF, Lai KN, Wang Y, Maxwell PH.

Nephrol Dial Transplant. 2010 May;25(5):1547-54. doi: 10.1093/ndt/gfp661. Epub 2009 Dec 22. Erratum in: Nephrol Dial Transplant. 2010 Jul;25(7):1.

PMID:
20031928
24.

Pathogenesis of small vessel vasculitis associated with autoantibodies to neutrophil cytoplasmic antigens: new insights from animal models.

Kain R, Firmin DA, Rees AJ.

Curr Opin Rheumatol. 2010 Jan;22(1):15-20. doi: 10.1097/BOR.0b013e328332c9e4. Review.

PMID:
19823088
25.

Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis.

Kain R, Exner M, Brandes R, Ziebermayr R, Cunningham D, Alderson CA, Davidovits A, Raab I, Jahn R, Ashour O, Spitzauer S, Sunder-Plassmann G, Fukuda M, Klemm P, Rees AJ, Kerjaschki D.

Nat Med. 2008 Oct;14(10):1088-96. doi: 10.1038/nm.1874. Epub 2008 Oct 5.

26.

Kim-1/Tim-1: from biomarker to therapeutic target?

Rees AJ, Kain R.

Nephrol Dial Transplant. 2008 Nov;23(11):3394-6. doi: 10.1093/ndt/gfn480. Epub 2008 Sep 3. No abstract available.

PMID:
18769021
27.

Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo.

Liu Y, Stewart KN, Bishop E, Marek CJ, Kluth DC, Rees AJ, Wilson HM.

J Immunol. 2008 May 1;180(9):6270-8.

28.

Healthy individuals have Goodpasture autoantigen-reactive T cells.

Zou J, Hannier S, Cairns LS, Barker RN, Rees AJ, Turner AN, Phelps RG.

J Am Soc Nephrol. 2008 Feb;19(2):396-404. doi: 10.1681/ASN.2007050546. Epub 2008 Jan 23.

29.

Interferon-beta: a novel way to treat nephrotic syndrome?

Rees AJ, Kain R.

J Am Soc Nephrol. 2007 Nov;18(11):2797-8. Epub 2007 Oct 17. No abstract available.

30.

A glass foreign body in the knee joint mistaken for ACL avulsion: an unusual case.

Sharma S, Rampurada A, Rees AJ.

Knee Surg Sports Traumatol Arthrosc. 2007 Jun;15(6):766-8. Epub 2006 Dec 23.

PMID:
17187276
31.

The role of infiltrating leukocytes in progressive renal disease: implications for therapy.

Rees AJ.

Nat Clin Pract Nephrol. 2006 Jul;2(7):348-9. No abstract available.

PMID:
16932458
32.
33.

Multiple facets of macrophages in renal injury.

Kluth DC, Erwig LP, Rees AJ.

Kidney Int. 2004 Aug;66(2):542-57. Review.

34.

Selective expression of TGF-beta2 and TGF-beta3 isoforms in early mesangioproliferative glomerulonephritis.

Minto AW, Wilson HM, Rees AJ, Quigg RJ, Brown PA.

Nephron Exp Nephrol. 2004;96(4):e111-8.

PMID:
15122060
35.

Macrophages and the kidney.

Wilson HM, Walbaum D, Rees AJ.

Curr Opin Nephrol Hypertens. 2004 May;13(3):285-90. Review.

PMID:
15073486
36.

Retransplantation in Alport post-transplant anti-GBM disease.

Browne G, Brown PA, Tomson CR, Fleming S, Allen A, Herriot R, Pusey CD, Rees AJ, Turner AN.

Kidney Int. 2004 Feb;65(2):675-81. Review.

37.

Heterogeneity of macrophage activation in anti-Thy-1.1 nephritis.

Minto AW, Erwig LP, Rees AJ.

Am J Pathol. 2003 Nov;163(5):2033-41.

38.

The fine specificity and cytokine profile of T-helper cells responsive to the alpha3 chain of type IV collagen in Goodpasture's disease.

Cairns LS, Phelps RG, Bowie L, Hall AM, Saweirs WW, Rees AJ, Barker RN.

J Am Soc Nephrol. 2003 Nov;14(11):2801-12.

39.

Macrophage heterogeneity in renal inflammation.

Erwig LP, Kluth DC, Rees AJ.

Nephrol Dial Transplant. 2003 Oct;18(10):1962-5. Review. No abstract available.

PMID:
13679464
40.

Bone-marrow-derived macrophages genetically modified to produce IL-10 reduce injury in experimental glomerulonephritis.

Wilson HM, Stewart KN, Brown PA, Anegon I, Chettibi S, Rees AJ, Kluth DC.

Mol Ther. 2002 Dec;6(6):710-7.

41.

Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo.

Mitchell S, Thomas G, Harvey K, Cottell D, Reville K, Berlasconi G, Petasis NA, Erwig L, Rees AJ, Savill J, Brady HR, Godson C.

J Am Soc Nephrol. 2002 Oct;13(10):2497-507.

42.

Retinal microenvironment controls resident and infiltrating macrophage function during uveoretinitis.

Robertson MJ, Erwig LP, Liversidge J, Forrester JV, Rees AJ, Dick AD.

Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2250-7.

PMID:
12091424
43.

Antigen presentation by macrophages is enhanced by the uptake of necrotic, but not apoptotic, cells.

Barker RN, Erwig LP, Hill KS, Devine A, Pearce WP, Rees AJ.

Clin Exp Immunol. 2002 Feb;127(2):220-5.

44.

Long-term outcome of anti-glomerular basement membrane antibody disease treated with plasma exchange and immunosuppression.

Levy JB, Turner AN, Rees AJ, Pusey CD.

Ann Intern Med. 2001 Jun 5;134(11):1033-42.

PMID:
11388816
45.

Macrophages in renal inflammation.

Erwig LP, Kluth DC, Rees AJ.

Curr Opin Nephrol Hypertens. 2001 May;10(3):341-7. Review.

PMID:
11342795
46.

Combinatorial model of chemokine involvement in glomerular monocyte recruitment: role of CXC chemokine receptor 2 in infiltration during nephrotoxic nephritis.

Zernecke A, Weber KS, Erwig LP, Kluth DC, Schröppel B, Rees AJ, Weber C.

J Immunol. 2001 May 1;166(9):5755-62.

47.

Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis.

Kluth DC, Ainslie CV, Pearce WP, Finlay S, Clarke D, Anegon I, Rees AJ.

J Immunol. 2001 Apr 1;166(7):4728-36.

48.

Properties of HLA class II molecules divergently associated with Goodpasture's disease.

Phelps RG, Jones V, Turner AN, Rees AJ.

Int Immunol. 2000 Aug;12(8):1135-43.

PMID:
10917888
49.

Transforming growth factor-beta isoforms and glomerular injury in nephrotoxic nephritis.

Wilson HM, Minto AW, Brown PA, Erwig LP, Rees AJ.

Kidney Int. 2000 Jun;57(6):2434-44.

50.

Differential effects of necrotic or apoptotic cell uptake on antigen presentation by macrophages.

Barker RN, Erwig L, Pearce WP, Devine A, Rees AJ.

Pathobiology. 1999;67(5-6):302-5.

PMID:
10725808

Supplemental Content

Support Center